<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00496899</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-07-AM-355-CITL</org_study_id>
    <nct_id>NCT00496899</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of New Computerized Labor Monitoring System</brief_title>
  <acronym>CLM</acronym>
  <official_title>Clinical Evaluation of New Computerized Labor Monitoring System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barnev Ltd</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barnev Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is an open label feasibility study. The purpose of the study is to evaluate the&#xD;
      ease of use of the Cervical ITR in terms of duration of attachment and number of detachments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Every year, millions of babies are born worldwide. Yet, despite great advances in medical&#xD;
      technology, the method used to obtain the most critical parameter in labor management -&#xD;
      cervix dilatation, remains a vaginal (manual) examination. This vaginal examination, intended&#xD;
      to estimate the dilatation of the cervix and the progress of the baby's head, is inaccurate,&#xD;
      non-continuous and involves the risk of infection to both fetus and mother. It is also&#xD;
      uncomfortable to the mother. The consequences of infections or delayed treatment may range&#xD;
      from simple complications to irreversible damage. Early detection of abnormal patterns of&#xD;
      labor progress could prevent complications and shorten the labor process and hospitalization,&#xD;
      thereby saving both aggravation and cost.&#xD;
&#xD;
      To truly manage the labor process, a labor management system is required. Such a system is&#xD;
      expected to provide the obstetrical staff with the flow of accurate, continuous, real-time&#xD;
      information, such as cervix dilatation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was stopped prematurally due to low recruiting&#xD;
  </why_stopped>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3</enrollment>
  <condition>Obstetrics</condition>
  <condition>Labor</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Women in active labor</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Laboring women reffered to maternity center in active labor (3 -7 cm)dilatation and&#xD;
        contraction&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Laboring women referred to the Maternity Center in active labor (3cm dilatation and&#xD;
             contractions).&#xD;
&#xD;
          -  Gestational age 37-42 weeks. (GA)&#xD;
&#xD;
          -  Single fetus&#xD;
&#xD;
          -  Subjects who understood, agreed and signed the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women with abnormal placentation (placenta previa)&#xD;
&#xD;
          -  Women with coagulation abnormalities.&#xD;
&#xD;
          -  Abnormal fetal presentation (breech presentation)&#xD;
&#xD;
          -  Maternal History of HIV and/or blood transmitted hepatitis and/or active genital&#xD;
             Herpes.&#xD;
&#xD;
          -  Preterm premature rupture of membranes.&#xD;
&#xD;
          -  Need for immediate delivery (cord prolapsed or suspected placental abruption&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel Many, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sackler school of medicine, Tel Aviv University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv soraski medical center</name>
      <address>
        <city>Tel - Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <study_first_submitted>July 4, 2007</study_first_submitted>
  <study_first_submitted_qc>July 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2007</study_first_posted>
  <last_update_submitted>May 8, 2008</last_update_submitted>
  <last_update_submitted_qc>May 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2008</last_update_posted>
  <responsible_party>
    <name_title>Clinical Trial Manager</name_title>
    <organization>Barnev</organization>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>Obstetric</keyword>
  <keyword>cervical dilatation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

